Company Quick10K Filing
InfuSystem
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-11-13 Exhibits
8-K 2019-11-12 Off-BS Arrangement, Exhibits
8-K 2019-11-08 Exhibits
8-K 2019-10-02 Officers, Exhibits
8-K 2019-09-30 Exhibits
8-K 2019-08-29 Exhibits
8-K 2019-08-14 Exhibits
8-K 2019-08-06 Exhibits
8-K 2019-06-11
8-K 2019-06-11 Exhibits
8-K 2019-05-22 Exhibits
8-K 2019-05-17 Officers, Exhibits
8-K 2019-05-14 Exhibits
8-K 2019-05-09
8-K 2019-03-07 Exhibits
8-K 2019-03-04 Exhibits
8-K 2019-02-27 Exhibits
8-K 2019-02-22 Exhibits
8-K 2019-02-05 Off-BS Arrangement, Exhibits
8-K 2018-12-19 Officers, Other Events, Exhibits
8-K 2018-11-13 Earnings, Exhibits
8-K 2018-08-14 Earnings, Exhibits
8-K 2018-07-31 Off-BS Arrangement, Exhibits
8-K 2018-07-19 Officers, Exhibits
8-K 2018-07-06 Exhibits
8-K 2018-07-05 Exhibits
8-K 2018-06-06 Officers
8-K 2018-04-25 Officers, Exhibits
8-K 2018-04-24 Earnings, Exhibits
8-K 2018-04-23 Earnings, Exhibits
8-K 2018-03-13 Earnings, Exhibits
8-K 2018-03-06 Earnings, Exhibits
8-K 2018-02-07 Officers, Regulation FD, Exhibits
8-K 2018-01-29 Other Events, Exhibits

InfuSystem Financials

-

INFU Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Pavmed (PAVM) 38,577 7,060 8,940 0 0 -6,485 -5,093 31,669
Restoration Robotics (HAIR) 25,740 23,175 36,157 19,801 8,882 -30,382 -29,504 42,050
Retractable Technologies (RVP) 23,852 36,263 10,497 35,655 10,716 50 1,087 22,920
Dynatronics (DYNT) 14,310 39,632 18,876 62,565 19,174 -336 -1,740 14,358
Isoray (ISR) 28,303 9,422 1,742 5,390 3,047 -5,144 -5,144 22,796
Dariohealth (DRIO) 21,001 12,326 6,232 7,472 1,575 -19,804 -19,804 13,015
Biolase (BIOL) 33,040 32,362 28,570 42,952 16,456 -20,383 -19,229 44,008
Ra Medical Systems (RMED) 45,828 69,280 9,483 5,800 1,378 -34,418 -34,350 -9,301
Co-Diagnostics (CODX) 13,864 5,318 512 85 37 -6,302 -6,247 10,008
Lianluo Smart (LLIT) 21,368 5,699 2,582 0 0 0 0 20,891
Hancock Jaffe Laboratories (HJLI) 18,997 7,253 2,601 103 72 -6,770 -6,653 13,722
Alliqua Biomedical (ALQA) 17,714 2,703 11,954 937 -10 -7,586 -5,012 19,826
Cytori Therapeutics (CYTX) 92 8,884 15,160 2,983 230 -16,863 -13,050 6,335
Invivo Therapeutics Holdings (NVIV) 6,891 13,608 3,140 0 0 -11,479 -11,414 -3,121
Neurometrix (NURO) 5,087 10,814 5,957 5,478 3,604 -3,028 -3,028 128
Inspiremd (NSPR) 5,030 9,284 3,710 3,360 794 -9,637 -9,637 207
Presbia (LENS) 4,530 2,986 20 -31 -8,416 -8,408 -2,527
InfuSystem (INFU) 72,361 72,643 72,156 41,089 -1,373 9,251 31,860
Daxor (DXR) 31,097 85,725 49,508 0 0 0 0 31,038
Pro Dex (PDEX) 8,812 25,520 8,512 28,594 10,531 5,017 6,991 5,673

Balance Sheet ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash79908041,4642,3264721029081,1384961,0411,9025153,2247919898185698051,0723,398194768033,4691,5302,3613,8824,3181,9001,702
Accounts Receivable7,3508,3207,7527,6298,5119,5709,4409,29110,69712,09910,76811,50510,30011,49812,30413,58414,20615,35916,95312,21611,58112,07911,54710,97111,38511,0879,89210,0439,59310,47511,218
Inventory3,2173,9183,8853,8041,3391,3781,3791,3431,2341,3981,4851,5891,7581,9791,8981,9071,9162,6222,0962,0652,1662,1351,9621,8731,7642,0631,9911,9852,2542,5532,742
PP&E15,76414,86414,44014,0378678487988138729151,5772,3702,4512,4572,3902,3212,3702,3082,2362,1406,1156,1136,1296,1376,1296,1506,2546,3226,0545,8696,144
Assets76,26375,63074,72374,02377,52376,22675,75176,39277,37378,25077,73581,02480,21387,46691,77993,77796,449100,164100,26797,08896,34491,89388,71085,33568,88164,96563,51763,99264,07367,24572,361
Accounts Payable4,0043,1804,7784,8572,1353,0563,8334,3294,7365,1534,1014,5705,2155,3676,3065,5266,5868,0145,3464,6765,3154,9025,2474,0935,5165,5455,9857,0597,0919,67210,206
Long-Term Debt
Liabilities36,09836,09335,52234,68737,51035,70434,94334,77234,65034,80133,37435,74233,76141,14144,27144,77945,17148,08647,32746,10945,65542,25940,01236,58937,92844,64145,52958,04758,42265,97772,643
Stockholders' Equity40,16539,53739,20139,33640,01340,52240,80841,62042,72343,44944,36145,28246,45246,32547,50848,99851,27852,07852,94050,97950,68949,63448,69848,74630,95331,23229,65520,60720,44119,74320,252
Income Statement ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Revenue14,34814,07214,17514,70114,66215,74017,17717,24217,87416,61316,26016,72517,17018,69219,53819,04419,06617,2262,01417,65416,94217,5883,03616,48316,41516,67717,56318,19319,723
Cost of Revenue2,2352,1482,3772,5792,8452,7503,1002,8902,9133,2213,1413,0153,6563,5803,5513,5064,7894,0183,8934,5365,1424,4524,7554,4794,8054,8965,1527,8528,367
Gross Profit10,43610,27410,19710,42310,33011,34011,58612,07612,65911,73011,62512,08911,85413,25813,98313,30712,08610,38910,65110,64910,60111,04111,33010,0739,5539,5489,84410,34111,356
R&D
SG&A9,0188,6787,6277,4397,4906,9746,7287,5648,1127,3997,2488,7128,6818,3388,4719,4848,7167,7578,3299,3518,7207,8239,0858,2988,5928,4838,5819,6369,261
Tax1443839-144429707349716842946-2851479571,011384337130-325-856-38532716,36458645-565963
Net Income-915-82833511056498645838868521,036-4157831,3692,00649572456-472-1,478-1,106-129-17,994204-505-519-275-960381
Cash Flow ($'000)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-30
Cash Operating873,5774,5991,6326012,5322,6981,0253,7783,2923,2961,2693,050
Cash Investing-1,273-536-1,411-684-154250-1,574-137-843-1,082-2,922-2,771-3,789
Cash Financing387-2,237-2,528-2,802-817-1,976-894-2,827-2,104-68962-916541